Kuehne + Nagel has opened a global distribution centre in Slovenia – the first logistic centre dedicated for pharma and healthcare in the Slovenian market.
The warehouse is one of the largest within the freight forwarder’s global KN PharmaChain network, expanding its standardised GxP compliant offering for the pharma & healthcare industry.
The new facility, which is strategically located in close vicinity to the Ljubljana Airport, will carry out the distribution of finished products worldwide and will be used for the storage and distribution of production materials for the pharmaceutical industry.
While eco-friendly built and equipped, the distribution centre complies with the highest security standards and state-of-the-art technology to increase current operational capacities.
The facility provides an area of approximately 38,000 square metres, a capacity of about 65,000 pallet locations for reception, storage and distribution of temperature-sensitive products and includes three cold chambers to handle temperature requirements of 15 to 25°C and 2 to 8°C.
Kuehne + Nagel’s said the development underlines its “continuous commitment” to expand its multi-modal and temperature-controlled forwarding and warehousing services worldwide.
With a global network of currently close to 200 certified operations, 600,000 square metres of industry dedicated warehousing space and a team of specially trained operators, KN PharmaChain addresses the need of pharma & healthcare customers for a standardised, reliable and compliant end-to-end logistics offering.
At the same time the company strengthens its presence in the Slovenian market, with an enhanced regional footprint.
Kuehne + Nagel member of the managing board responsible for contract logistics, Gianfranco Sgro said: “The pharma & healthcare Industry is among the most important growth drivers for Kuehne + Nagel. Therefore, it is of strategic importance to further strengthen our integrated KN PharmaChain network.
“The cutting-edge facility in Brnik is a cornerstone in this ambition and enables Kuehne + Nagel to offer its unique pharma solutions to an extended customer base.”